// App-Quantinova.ai

: Single Cycle of Blinatumomab Followed By High-Dose Chemotherapy in the Induction Therapy for Ph-Negative Acute Lymphoblastic Leukemia in Adults. Primary Endpoint Analysis of the Blina-Cell Trial

Researchers

Presenter

  • Cyril Salek

Principal Investigators

  • Frantisek Folber

  • Stepan Hrabovsky

  • Zdenek Koristek

  • Jan M Horacek

  • Eva Fronkova

  • Petr Soukup

  • Katerina Benkova

  • Petr Cetkovsky

  • Jan Trka

  • Michael Doubek

Medical Centers

  • Department of Internal Medicine IV - Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic

  • Internal Medicine, University of Defence, Faculty of Military Health Sciences, Hradec Kralove, Czech Republic

  • Department of Hematooncology, University of Ostrava, Faculty of Medicine, Ostrava, Czech Republic

  • CLIP - Childhood Leukaemia Investigation Prague, Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic

  • CLIP, Dept. of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic

  • Institute of Clinical and Experimental Hematology, Charles University in Prague, First Faculty of Medicine, Prague, Czech Republic

  • Institute of Hematology and Blood Transfusion, Prague, Czech Republic

  • Department of Internal Medicine - Hematology and Oncology, University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic

  • Charles University, First Faculty of Medicine, Prague, Czech Republic

Locations

  • Czech Republic

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Blinatumomab

  • Daunorubicin

  • Methotrexate

  • Vincristine

  • Cytarabine liposomal

  • Etoposide

  • Etoposide phosphate

  • Vindesine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A